Clinical Trial Update: The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial completed evaluating the role of matrix metalloproteinases in primary teeth pulpotomy treatments for reversible pulpitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reversible Pulpitis

Snippet

Sponsor: Ege University | Conditions: Reversible Pulpitis | Phase 1, Phase 2 | Status: COMPLETED